RecallDepth
Class II Ongoing

Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-474-60.

Company
Ascend Laboratories, Llc
Recall Initiated
March 14, 2023
Posted
April 5, 2023
Recall Number
D-0533-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
13,560 bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot #s: 22142462, 22142463, 22142464, Exp 5/2024; 22143000, 22143001, 22143002, Exp 6/2024.

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls